英为财情Investing.com - Akoya Biosciences (NASDAQ: AKYA )星期四发布了第三季度的财报，数据显示，公司营收逊于分析师的预期，每股收益低于分析师的预期。 在该公司发布的最新财报中，公司每股收益为$-0.210，总营收为$18.8M，而此前英为财情Investing.com对分析师的调查显示，分析师预期该公司的营收为$25.43M，每股收益为$-0.200 ...

Akoya Biosciences, Inc. (Nasdaq: AKYA) (“Akoya”), The Spatial Biology Company®, today announced its financial results for the third quarter ending September 30, 2024. “Our third-quarter results came ...

Akoya Biosciences (AKYA) came out with a quarterly loss of $0.18 per share versus the Zacks Consensus Estimate of a loss of $0.19. This compares to loss of $0.26 per share a year ago. These figures ...

MARLBOROUGH, Mass. (AP) — MARLBOROUGH, Mass. (AP) — Akoya Biosciences Inc. (AKYA) on Thursday reported a loss of $10.5 million in its third quarter. On a per-share basis, the Marlborough, ...

Akoya Biosciences (NASDAQ:AKYA – Get Free Report) will announce its earnings results after the market closes on Thursday, ...

Nov. 05, 2024 (GLOBE NEWSWIRE) -- Akoya Biosciences, Inc. (Nasdaq: AKYA) (“Akoya”), The Spatial Biology Company ®, will unveil innovations designed to accelerate insights in immuno-oncology (IO) and ...

In a report released today, William Bonello from Craig-Hallum maintained a Buy rating on Akoya Biosciences (AKYA – Research Report). The ...

The global environmental test equipment market is projected to be valued at USD 1.2 billion in 2023, with a growth rate of ...

Investing.com - Akoya Biosciences (NASDAQ: AKYA) reported second quarter EPS of $-0.51, $0.07 worse than the analyst estimate of $-0.44. Revenue for the quarter came in at ...

Akoya Biosciences. "With this new offering, we’re extending the impact of spatial biology in critical stages of drug development, providing the tools to explore key biological insights early in ...

Nov. 05, 2024 (GLOBE NEWSWIRE) -- Akoya Biosciences, Inc. (Nasdaq: AKYA) (“Akoya”), The Spatial Biology Company ®, will unveil innovations designed to accelerate insights in immuno-oncology ...

Featured here, the Balance Sheet for Akoya Biosciences Inc, which summarizes the company's financial position including assets, liabilities and shareholder equity for each of the latest 10 period ...